Reversal of Diabetic Dry Eye by Topical Opioid Receptor Blockade Follows Dual Pathways. Diaz D, Sassani JW, Zagon IS, McLaughlin PJ, et al. Invest Ophthalmol Vis Sci 2025;66:24.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Diaz D, Sassani JW, Zagon IS, McLaughlin PJ, et al. Reversal of Diabetic Dry Eye by Topical Opioid Receptor Blockade Follows Dual Pathways. Invest Ophthalmol Vis Sci 2025;66:24.
PMID: 40062813